Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > MBX Lofty targets (Microbix Biosystems Inc.)

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Apr 13, 2022 1:15pm

163 Views

Post# 34600976

RE:MBX Lofty targets (Microbix Biosystems Inc.)

The market does not believe the analysts or management at this time. They need to show the results. MBX is stronger than it has ever been and the current leadership is executing on their strategy. As you said, when it inevitably goes higher it will go very fast. Q4, ending September, will be the first to show the results of the massive expansion effort, but I believe Q2 and Q3 should also be records.Just hold tight and accumulate until then.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in